IGI Logo

The expected listing of Glenmark Life Science IPO will be on 6^th August 2021, investors will be getting shares in their Demat account today. Glenmark IPO received a good response from retail investors as well as institutional investors and overall IPO got oversubscribed by 44.1 times. We expect Glenmark to debut on the stock market near price to earnings of 25-27 times i.e ₹810-₹870 as peers are trading in this rage and even Glenmark life science has a better return ratio, so we expect listing gains will be in between 12% to 20%. We will suggest retail investors book partial profit if listing gains are in the above range and long-term investors can hold the IPO as we expect Glenmark life science to do better than the industry in the long term. We had assigned a subscribe rating to Glenmark IPO. 

Above views are of the author and not of the website kindly read disclaimer